131 related articles for article (PubMed ID: 17768144)
1. Successful interventional closure of a patent foramen ovale in a pediatric patient supported with a biventricular assist device.
Loeffelbein F; Schlensak C; Beyersdorf F; Dittrich S
Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):778-9. PubMed ID: 17768144
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of patent foramen ovale for hypoxemia during left ventricular assist device support.
Loforte A; Violini R; Musumeci F
J Card Surg; 2012 Jul; 27(4):528-9. PubMed ID: 22607124
[TBL] [Abstract][Full Text] [Related]
3. Bailout transcatheter closure of patent foramen ovale for refractory hypoxaemia after left ventricular assist device implantation.
Fischer Q; Kirsch M; Brochet E; Juliard JM
Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):246-8. PubMed ID: 25912477
[TBL] [Abstract][Full Text] [Related]
4. Delayed intracardial shunting and hypoxemia after massive pulmonary embolism in a patient with a biventricular assist device.
Weig T; Dolch ME; Frey L; Bruegger D; Boekstegers P; Sodian R; Irlbeck M
J Cardiothorac Surg; 2011 Oct; 6():133. PubMed ID: 21989045
[TBL] [Abstract][Full Text] [Related]
5. Amplatzer™ occlusion device implantation in a patient with biventricular HeartWare®.
Arif R; Ruhparwar A; Kallenbach K; Weymann A; Schmack B; Karck M; Gorenflo M
Int J Artif Organs; 2014 Jan; 37(1):93-5. PubMed ID: 24634338
[TBL] [Abstract][Full Text] [Related]
6. Patent Foramen Ovale Closure for Hypoxemia.
Tobis JM; Narasimha D; Abudayyeh I
Interv Cardiol Clin; 2017 Oct; 6(4):547-554. PubMed ID: 28886845
[TBL] [Abstract][Full Text] [Related]
7. Hypoxemia complicating LVAD insertion: novel application of the Amplatzer PFO occlusion device.
Srinivas CV; Collins N; Borger MA; Horlick E; Murphy PM
J Card Surg; 2007; 22(2):156-8. PubMed ID: 17338756
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of percutaneous closure of patent foramen ovale for hypoxemia.
Fenster BE; Nguyen BH; Buckner JK; Freeman AM; Carroll JD
Am J Cardiol; 2013 Oct; 112(8):1258-62. PubMed ID: 23871675
[TBL] [Abstract][Full Text] [Related]
10. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
Knerr M; Bertog S; Vaskelyte L; Hofmann I; Sievert H
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1144-51. PubMed ID: 24323667
[TBL] [Abstract][Full Text] [Related]
11. [Patent foramen ovale presented hypoxemia with cardiac sarcoidosis].
Yusa H; Misumi H; Sakaguchi H; Uesugi H; Ideta I; Sassa T; Miyamoto T; Hirayama T
Kyobu Geka; 2008 Nov; 61(12):1019-22. PubMed ID: 19048899
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVAD.
Bartoli CR; McCants KC; Birks EJ; Flaherty MP; Slaughter MS
J Invasive Cardiol; 2013 Mar; 25(3):154-6. PubMed ID: 23468448
[TBL] [Abstract][Full Text] [Related]
13. [Patent foramen ovale and hypoxaemia with or without elevated right heart pressures].
Bancal C; Arnoult F; Krapf L; Bonay M
Rev Mal Respir; 2011 Oct; 28(8):967-77. PubMed ID: 22099402
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Closure of Patent Foramen Ovale in the Setting of Pulmonary Embolism (Right-Left Shunt Causing Severe Hypoxia).
Johnson J; Kodra A; Basman C; Scheinerman SJ; Patel N; Kliger C
Innovations (Phila); 2020; 15(5):478-480. PubMed ID: 32758050
[TBL] [Abstract][Full Text] [Related]
15. Rescue treatment by percutaneous closure of interatrial septal defect or PFO in infants with Berlin heart.
Gagliardi MG; Papavasileiou L; Pongiglione G
Catheter Cardiovasc Interv; 2011 Mar; 77(4):577-9. PubMed ID: 20853353
[TBL] [Abstract][Full Text] [Related]
16. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study.
Sievert H; Wunderlich N; Reiffenstein I; Ruygrok P; Grube E; Buellesfeld L; Meier B; Schofer J; Muller D; Jones RK; Gillam L
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1135-43. PubMed ID: 22815250
[TBL] [Abstract][Full Text] [Related]
17. Patent foramen ovale-related complications in left ventricular assist device patients: a reappraisal for cardiovascular professionals.
Bacich D; Fiorencis A; Braggion G; Zuin M; Rigatelli G
J Artif Organs; 2020 Jun; 23(2):98-104. PubMed ID: 31463532
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter closure of patent foramen ovale for hypoxemia during left ventricular assist device support.
Nguyen DQ; Das GS; Grubbs BC; Bolman RM; Park SJ
J Heart Lung Transplant; 1999 Oct; 18(10):1021-3. PubMed ID: 10561114
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement.
Kapur NK; Conte JV; Resar JR
J Invasive Cardiol; 2007 Sep; 19(9):E268-70. PubMed ID: 17827518
[TBL] [Abstract][Full Text] [Related]
20. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
